Sign in to view content

Do scheduling issues impact commonly needed testing for patients with moderate diabetic retinopathy with macular edema?

Leonard H. Ginsburg, MD

Video
Published 2019

Related

Diabetic Retinopathy Progression in the Absence of Therapy: An Analysis of Untreated Fellow Eyes in RIDE and RISE
Sophie Jane Bakri, MD
Annual Meeting Talks
2019
Widefield Fluorescein Angiographic-Guided Aflibercept (WFFAGA) Monotherapy for Proliferative Diabetic Retinopathy (PDR)
Dennis M. Marcus, MD
Annual Meeting Talks
2019
Risk of Sight-Threatening Diabetic Retinopathy with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes
Andrew J. Barkmeier, MD
Updates from the Field
2024

Category: Practice Management - Coding - Computers

See more